Below is Validea's guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA). Of the 22 guru strategies we follow, TEVA rates highest using our Twin Momentum Investor model based ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

After hours: 7:57:48 p.m. EST ...

1 Day TEVA 1.11% DJIA 0.78% S&P 500 1.00% Health Care/Life Sciences 66.70% ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

It is the first company in the world ever to have achieved an FDA product clearance for harvesting intact cancer cells for analysis. Shares in the company rose 57% in the wake of the approval ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Objective Breakthrough cancer pain (BTcP) is common and has a significant impact on the quality of life of patients with cancer. This review compares current national/international BTcP guidelines in ...

Michael L. Krychman, MD; Jan L. Shifren, MD, NCMP; James H. Liu, MD; Sheryl L. Kingsberg, PhD; Wulf H. Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS ...